Literature DB >> 22705846

The TNF family member APRIL promotes colorectal tumorigenesis.

V Lascano1, L F Zabalegui, K Cameron, M Guadagnoli, M Jansen, M Burggraaf, M Versloot, H Rodermond, C van der Loos, C E Carvalho-Pinto, H Kalthoff, J P Medema, M Hahne.   

Abstract

The tumor necrosis factor (TNF) family member APRIL (A proliferation inducing ligand) is a disease promoter in B-cell malignancies. APRIL has also been associated with a wide range of solid malignancies, including colorectal cancer (CRC). As evidence for a supportive role of APRIL in solid tumor formation was still lacking, we studied the involvement of APRIL in CRC. We observed that ectopic APRIL expression exacerbates the number and size of adenomas in Apc(Min) mice and in a mouse model for colitis-associated colon carcinogenesis. Furthermore, knockdown of APRIL in primary spheroid cultures of colon cancer cells and both mouse and human CRC cell lines reduced tumor clonogenicity and in vivo outgrowth. Taken together, our data therefore indicate that both tumor-derived APRIL and APRIL produced by non-tumor cells is supportive in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705846      PMCID: PMC3469063          DOI: 10.1038/cdd.2012.68

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  41 in total

1.  TACI regulates IgA production by APRIL in collaboration with HSPG.

Authors:  Daisuke Sakurai; Hidenori Hase; Yumiko Kanno; Hidefumi Kojima; Ko Okumura; Tetsuji Kobata
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

2.  The source of APRIL up-regulation in human solid tumor lesions.

Authors:  P Mhawech-Fauceglia; G Kaya; G Sauter; T McKee; O Donze; J Schwaller; B Huard
Journal:  J Leukoc Biol       Date:  2006-06-22       Impact factor: 4.962

3.  Hereditary gastrointestinal polyposis and nonpolyposis syndromes.

Authors:  A K Rustgi
Journal:  N Engl J Med       Date:  1994-12-22       Impact factor: 91.245

4.  Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

Authors:  J Hendriks; L Planelles; J de Jong-Odding; G Hardenberg; S T Pals; M Hahne; M Spaargaren; J P Medema
Journal:  Cell Death Differ       Date:  2005-06       Impact factor: 15.828

5.  APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival.

Authors:  Lourdes Planelles; Sonia Castillo-Gutiérrez; Jan Paul Medema; Antonio Morales-Luque; Hélène Merle-Béral; Michael Hahne
Journal:  Haematologica       Date:  2007-09       Impact factor: 9.941

6.  Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.

Authors:  Bing He; Weifeng Xu; Paul A Santini; Alexandros D Polydorides; April Chiu; Jeannelyn Estrella; Meimei Shan; Amy Chadburn; Vincenzo Villanacci; Alessandro Plebani; Daniel M Knowles; Maria Rescigno; Andrea Cerutti
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

7.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

Review 8.  An APRIL to remember: novel TNF ligands as therapeutic targets.

Authors:  Stacey R Dillon; Jane A Gross; Stephen M Ansell; Anne J Novak
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

9.  Identification of proteoglycans as the APRIL-specific binding partners.

Authors:  Karine Ingold; Adrian Zumsteg; Aubry Tardivel; Bertrand Huard; Quynh-Giao Steiner; Teresa G Cachero; Fang Qiang; Leonid Gorelik; Susan L Kalled; Hans Acha-Orbea; Paul D Rennert; Jürg Tschopp; Pascal Schneider
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.

Authors:  M Hahne; T Kataoka; M Schröter; K Hofmann; M Irmler; J L Bodmer; P Schneider; T Bornand; N Holler; L E French; B Sordat; D Rimoldi; J Tschopp
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  13 in total

1.  Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.

Authors:  Cecilia Rocha; Laura Papon; Wulfran Cacheux; Patricia Marques Sousa; Valeria Lascano; Olivia Tort; Tiziana Giordano; Sophie Vacher; Benedicte Lemmers; Pascale Mariani; Didier Meseure; Jan Paul Medema; Ivan Bièche; Michael Hahne; Carsten Janke
Journal:  EMBO J       Date:  2014-09-01       Impact factor: 11.598

2.  APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.

Authors:  Guihua Wang; Feng Wang; Weifeng Ding; Jingchun Wang; Rongrong Jing; Haiquan Li; Xudong Wang; Yueguo Wang; Shaoqing Ju; Huimin Wang
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

3.  Amelioration of colorectal cancer using negative lipidoid nanoparticles to encapsulate siRNA against APRIL by enema delivery mode.

Authors:  Weifeng Ding; Guihua Wang; Keke Shao; Feng Wang; Hua Huang; Shaoqing Ju; Hui Cong; Huimin Wang
Journal:  Pathol Oncol Res       Date:  2014-04-26       Impact factor: 3.201

4.  The design and characterization of receptor-selective APRIL variants.

Authors:  Fiona C Kimberley; Almer M van der Sloot; Marco Guadagnoli; Katherine Cameron; Pascal Schneider; J Arnoud Marquart; Miranda Versloot; Luis Serrano; Jan Paul Medema
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

5.  APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells.

Authors:  Feng Wang; Lin Chen; Hongbin Ni; Guihua Wang; Weifeng Ding; Hui Cong; Shaoqing Ju; Shumei Yang; Huimin Wang
Journal:  Mol Cell Biochem       Date:  2013-07-20       Impact factor: 3.396

6.  Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Authors:  Giuseppe S Sica; Cristina Fiorani; Carmine Stolfi; Giovanni Monteleone; Eleonora Candi; Ivano Amelio; Valeria Catani; Simone Sibio; Andrea Divizia; Giorgia Tema; Edoardo Iaculli; Achille L Gaspari
Journal:  Oncotarget       Date:  2015-05-30

7.  Identification of the sAPRIL binding peptide and its growth inhibition effects in the colorectal cancer cells.

Authors:  Xiao-qing He; Jing Guan; Fang Liu; Jing Li; Mei-rong He
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

8.  APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer.

Authors:  Hengli Dou; Zhaohua Yan; Meng Zhang; Xiaoxin Xu
Journal:  Oncol Lett       Date:  2016-09-06       Impact factor: 2.967

9.  Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients.

Authors:  V Lascano; M Hahne; L Papon; K Cameron; C Röeder; C Schafmayer; L Driessen; H van Eenennaam; H Kalthoff; J P Medema
Journal:  Oncogenesis       Date:  2015-01-26       Impact factor: 7.485

10.  p63 transcriptionally regulates the expression of matrix metallopeptidase 13.

Authors:  Ivana Celardo; Alexey Antonov; Ivano Amelio; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Oncotarget       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.